Renascience Pharma Limited
09420886
Healthy
- Current liabilities exceed current assets (-10)
- Going concern doubt noted in accounts (-10)
Details
Compliance
Last accounts
31/03/2026
full
Next accounts due
31/12/2027
Confirmation statement
Last: 02/04/2026
Due 16/04/2027
Industry
Officers
director · Since 02/04/2025
PRESIDENT OF EMEA
FRENCH · SWITZERLAND · Age 68
director · Since 02/04/2025
COMPANY DIRECTOR
BRITISH · ENGLAND · Age 55
Also on 2 other boards
secretary · Since 02/04/2025
secretary · Since 02/04/2025
Former
director · Resigned 02/04/2025
director · Resigned 02/04/2025
director · Resigned 02/04/2025
director · Resigned 02/04/2025
Persons with Significant Control
Lupin Healthcare (Uk) Limited
The Urban Building Second Floor, 3-9 Albert Street, Slough, SL1 2BE
Reg: 06925119 · Companies House · Private Limited Company
Notified 02/04/2025
Former PSCs
Mr Ka Yan Che
Ceased 02/04/2025
Mr Haziq Patel
Ceased 02/04/2025
Mr Mobeen Akhtar
Ceased 02/04/2025
Mr Peter Mollison
Ceased 02/04/2025
Change History
Active
Private Limited Company
THE URBAN BUILDING SECOND FLOOR
SLOUGH
CompanyRankvs 79+ SIC 21100 peers71
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Going concern doubt: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Going Concern Doubt
conformity with the requirements of the Companies Act 2006 , subject to any material departures disclosed and explained in the financial statements; ∙ assess the Company 's ability to continue as a going concern, disclosing, as applicable, matters related to going concern; and ∙ use the going concern basis of accounting unless they either intend to liquidate the Company or to cease operations, o
Key FinancialsYear ending 31/03/2025
Turnover
£3.7M
Annual revenue
Net Worth
£960k
Balance sheet strength
Cash
£902k
Cash in the bank
Profit Before Tax
£1.8M
Bottom line earnings
Net Current Assets
—
Working capital
Current Assets
£1.8M
Current Liabilities
£862k
Debtors
£720k
Cost of Sales
£1.3M
Gross Profit
£2.4M
Admin Expenses
£573k
Operating Profit
£1.8M
Profit After Tax
£1.3M
Tax at Year End
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 2.11 | +£0 |
| 2025 | 2.11 | +£711k |
| 2024 | 1.73 | -£59k |
| 2023 | 4.46 | — |
Derived from filed accounts. Not audited figures.